GLTO Company Profile and Key Details

Galecto, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $12.19. This means the shares are trading above this model’s fair value.

GLTO has shown sold momentum, gaining 27.98% over the past week and 191.49% over the past quarter, though year-to-date performance is up 21.36%. Short-term trend indicators are mixed aligned (SMA20 18.08%, SMA50 17.39%, SMA200 176.95%). The stock’s 14-day RSI is 60.26 (firm momentum), while the ATR of 3.31 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.64% below its high and over 1394.03% above its low. Average 10-day trading volume of 437.02 thousand shares is significantly above the 3-month average of 249.73 thousand, indicating heightened recent market interest.

Galecto, Inc. generated EPS of -$12.10 over the past year. Five-year average earnings growth is 14.83%. Wall Street analysts project EPS growth of 53.78% annually over the next five years. The latest quarter delivered EPS of -$5.22. The next quarter is forecast at -$0.14. Next year's EPS is expected at $19.48. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $46.00 to $32.00. The high target offers 53.18% upside. The low target suggests 6.56% downside. The mean target is $38.00. This offers 26.54% upside. Galecto, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended March 19, 2025, missed forecasts by 67.31%. The prior quarter beat by -99.92%. Over the last six quarters, Apple has recorded several small beats. These include -36.17% in November 06, 2023.

Galecto, Inc. (NASDAQ:GLTO) closed at $30.03 USD, gaining $8.23 (37.75%) from the previous close of $21.80. The stock is currently mid-range between its 52-week high and low $2.01 and $38.33. With a market capitalization of about $47.97 million, Galecto, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.46). Key stats such as the average daily volume over the past year has been around 168.19 thousand shares, trading with heavier-than-usual volume. Headquartered in Boston, MA, Galecto, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Hans T. Schambye, the company employs approximately 5 people and listed since October 29, 2020. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases.

Galecto, Inc. has 1.32 million shares outstanding. The public float is 1.22 million shares, elevated short interest at 2.15% of float. This equals 27.46 thousand shares. The short ratio is 1.0 days. Institutional investors hold 12.72% of the float. Insiders own 3.68%. Novo Holdings A/S holds 2.50 million shares, Khuong Chau Quang has 1.03 million shares and Christgau Stephan has 546.14 thousand shares. Over the past six months, insider transactions show net selling. They sold 1.09 thousand shares across 3 transactions.

Our AI price prediction model suggests that Galecto, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -29.3%, with price expected at $21.23 by February 25, 2026, within a range of $17.44 to $24.95 3-Month Outlook: Projected fall of -20.61%, reaching $23.84 by May 12, 2026, with a range of $23.23 to $24.44. 1-Year Outlook: Projected loss of -63.0%, with price at $11.11 by February 11, 2027, within a range of $5.42 to $15.62.

Galecto, Inc. (NASDAQ:GLTO) shares are up 21.36% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Galecto, Inc. trading at a premium to the broader market with a P/E of -2.33. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $16.93, suggesting -43.62% downside. Our AI forecast model points to short-term weakness (-29.3% over two weeks), a medium-term fall (-20.61% over three months), and a longer-term loss (-63.0% over one year), with expected trading ranges indicating moderate volatility.

Galecto, Inc. trades at a P/E ratio of -2.33, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 5.54 trading at moderately above to book value. The P/FCF stands at -3.63, also above market averages.